covid-19
Showing NaN - NaN of 62
Predictors of Severe COVID-19 Outcomes
Active, not recruiting
- Acute Respiratory Distress Syndrome
- COVID-19
-
Tucson, Arizona
- +7 more
Aug 16, 2021
COVID-19 in Patients With Chronic Liver Diseases
Completed
- COVID-19
- Chronic Liver Disease
- Prospective Chart Review
-
Phoenix, Arizona
- +22 more
Aug 5, 2021
COVID-19, Acute Respiratory Distress Syndrome Trial in United States (Razuprotafib Subcutaneous Solution, Placebo Subcutaneous
Terminated
- COVID-19
- Acute Respiratory Distress Syndrome
- Razuprotafib Subcutaneous Solution
- Placebo Subcutaneous Solution
-
Los Angeles, California
- +6 more
Jun 15, 2021
COVID-19, Pneumonia, Viral, Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) Trial in France, United States
No longer available
- COVID-19
- +2 more
- eculizumab
-
Los Angeles, California
- +11 more
Mar 5, 2021
COVID-19, Sars-CoV2 Trial in Los Angeles (Progesterone 100 MG)
Completed
- COVID-19
- Sars-CoV2
- Progesterone 100 MG
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Jan 25, 2021
COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)
Health and Wellbeing of Pregnant and Post-Partum Women During
Completed
- COVID-19
- +6 more
- This is an online survey with no intervention.
-
Los Angeles, CaliforniaPregistry
Jan 5, 2021
COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)
COVID-19 Trial in Los Angeles (CAP-1002 Allogeneic Cardiosphere-Derived Cells)
No longer available
- COVID-19
- CAP-1002 Allogeneic Cardiosphere-Derived Cells
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 29, 2020
Covid-19, Critical Illness, Attitude of Health Personnel Trial in Los Angeles (Brief educational video)
Active, not recruiting
- Covid-19
- +5 more
- Brief educational video
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Oct 11, 2020
COVID-19 Trial in Los Angeles (Positive COVID Test Result - Hypothetical Scenario, Negative COVID Test Result - Hypothetical
Completed
- COVID-19
- Positive COVID Test Result - Hypothetical Scenario
- +2 more
-
Los Angeles, CaliforniaUCLA Health Department of Medicine, Quality Office
Aug 19, 2020